89bio Inc (ETNB)
8.80
+0.29
(+3.41%)
USD |
NASDAQ |
May 01, 11:59
89bio Accounts Payable (Quarterly): 8.585M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.585M |
| September 30, 2023 | 10.90M |
| June 30, 2023 | 10.72M |
| March 31, 2023 | 16.73M |
| December 31, 2022 | 12.50M |
| September 30, 2022 | 14.15M |
| June 30, 2022 | 4.907M |
| March 31, 2022 | 4.421M |
| December 31, 2021 | 6.843M |
| September 30, 2021 | 12.53M |
| Date | Value |
|---|---|
| June 30, 2021 | 1.915M |
| March 31, 2021 | 4.521M |
| December 31, 2020 | 2.065M |
| September 30, 2020 | 4.086M |
| June 30, 2020 | 3.07M |
| March 31, 2020 | 4.055M |
| December 31, 2019 | 0.989M |
| September 30, 2019 | 3.571M |
| June 30, 2019 | 0.968M |
| December 31, 2018 | 1.509M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.968M
Minimum
Jun 2019
16.73M
Maximum
Mar 2023
6.712M
Average
4.521M
Median
Mar 2021
Accounts Payable (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 28.04M |
| Akero Therapeutics Inc | 7.038M |
| Viking Therapeutics Inc | 5.225M |
| Galectin Therapeutics Inc | 6.431M |
| Terns Pharmaceuticals Inc | 2.515M |